Both in Pharmaceuticals

RenovoRx vs XBiotech

Over the past year RNXT returned +31.0% and XBIT returned −21.7%; their daily moves had a correlation of 0.13.

RNXT +31.0% XBIT −21.7%Growth of $1, one year, split-adjusted
MetricRNXTXBIT
Price$1.33$1.88
Market cap$60.0M$57.3M
Today−10.74%−3.09%
1 month−14.2%−14.5%
6 months+50.6%−26.3%
Year to date+58.3%−21.3%
1 year+26.7%−20.7%
Revenue growth (YoY)+115.4%—
Gross margin84.3%—
Net margin−320.2%—
P/E (TTM)——
Price / sales30.4×—
Net cash$9.5M$109.5M
Dividend yield——
Volatility (60d)108.0%34.9%
Short % of float2.0%1.8%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).